Ginascol John F
SEC CIK 1778075 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | EVP | 118.4K | — | $1.37M | 10 | 2021-03-01 | 2023-03-01 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
Ginascol John F made no open-market trades at ABT in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | ABT | Abbott Laboratories | Ginascol John F | EVP | S - Sale | $100.70 | -943 | 118.4K | -0.8% | -$95.0K | |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | Ginascol John F | EVP | F - Tax | $99.77 | -6,859 | 119.3K | -5% | -$684.3K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | Ginascol John F | EVP | A - Grant | $0.00 | +14.3K | 126.2K | +13% | $0 |
| 2022-12-15 | 2022-12-13 | ABT | Abbott Laboratories | Ginascol John F | EVP | S - Sale | $112.32 | -11.0K | 111.9K | -9% | -$1.24M | |
| 2022-06-07 | 2022-06-03 | ABT | Abbott Laboratories | Ginascol John F | EVP | F - Tax | $117.51 | -1,768 | 122.9K | -1% | -$207.8K | |
| 2022-03-02 | 2021-03-01 | ABT | Abbott Laboratories | Ginascol John F | EVP | S - Sale | $118.16 | -365 | 124.7K | -0.3% | -$43.1K | |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | Ginascol John F | EVP | F - Tax | $122.41 | -5,876 | 125.0K | -4% | -$719.3K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | Ginascol John F | EVP | A - Grant | $0.00 | +17.2K | 130.9K | +15% | $0 |
| D | 2021-10-27 | 2021-10-27 | ABT | Abbott Laboratories | Ginascol John F | EVP | M - OptEx | $47.00 | +45.7K | 143.3K | +47% | +$2.15M |
| D | 2021-10-27 | 2021-10-27 | ABT | Abbott Laboratories | Ginascol John F | EVP | F - Tax | $128.13 | -29.6K | 113.7K | -21% | -$3.79M |
Purchase Sale Sale after option exercise All abbreviations